Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.

Also called NCT05282836

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 206 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05282836
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05282836. Randomized; single masking; primary purpose treatment. Start 2022-03-15 (anticipated); primary completion 2023-03-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA)
Acronym
HOMA
Condition
Aneurysmal Subarachnoid Hemorrhage
Intervention (Device)
Hydrogen Oxygen Generator with Nebulizer
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct05282836
Content hash
50496a222cc3f2a2df014c0bff412d154f1e1b7654b082a04213b4ef12255a62